Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls
Authors:
- 9 September 2020
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 21 (10) , 625-634
Abstract
Objectives People living with HIV (PLWH) have increased risk of cardiovascular diseases compared with uninfected populations. We assessed structural cardiac abnormalities and their associated risk factors in well‐treated PLWH and uninfected controls using multidetector computed tomography (MDCT). Methods People living with HIV and age‐ and sex‐matched uninfected controls underwent MDCT to determine left atrial volume (LAV), left ventricular diastolic volume (LVDV), right ventricular diastolic volume (RVDV) and left ventricular mass (LVM). All outcomes were indexed to body surface area (BSA) (LAVi, LVDVi, RVDVi and LVMi). Results A total of 592 PLWH and 1184 uninfected controls were included in the study. PLWH had smaller mean (SD) LAVi [40 (8) vs. 41 (9) mL/m2; P = 0.002] and LVDVi [61 (13) vs. 65 (14) mL/m2; P < 0.001] but larger RVDVi [89 (18) vs. 86 (17) mL/m2; P < 0.001] than uninfected controls. HIV was independently associated with 7 mL (95% CI: −10 to −3) smaller LVDV, and with 12 mL (95% CI: 8–16) larger RVDV, and 4 g (95% CI: 1–6) larger LVM after adjustment for cardiovascular risk factors and BSA. Large RVDV in PLWH was not associated with obstructive lung function. Conclusions HIV was independently associated with smaller LVDV and larger RVDV and LVM. Alterations in cardiac chamber volumes in PLWH were mainly minor. The clinical impact of these findings is uncertain, but it seems unlikely that alterations in cardiac chamber volumes explain the increased burden of cardiovascular disease previously observed in PLWH.Keywords
Funding Information
- Novo Nordisk Fonden
This publication has 42 references indexed in Scilit:
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAIDS, 2013
- Association of Left Ventricular Mass with All-Cause Mortality, Myocardial Infarction and StrokePLOS ONE, 2012
- Impact of HIV Infection on Diastolic Function and Left Ventricular MassCirculation: Heart Failure, 2010
- The Association of HIV Infection with Left Ventricular Mass/HypertrophyAIDS Research and Human Retroviruses, 2009
- Noninvasive Coronary Artery ImagingCirculation, 2008
- Subclinical Cardiac Abnormalities in Human Immunodeficiency Virus–Infected Men Receiving Antiretroviral TherapyThe American Journal of Cardiology, 2008
- Myocardial disease in human immunodeficiency virus (HIV) infection: a reviewWiener klinische Wochenschrift, 2008
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculographyAmerican Heart Journal, 2004
- Prevalence of cardiac abnormalities in human immunodeficiency virus infectionThe American Journal of Cardiology, 1989